Imprimis NJOF, LLC recalls Dexamethasone Moxifloxacin Ketorolac, 1 mg/mL, 0.5 mg/mL, 0.4 mg/mL) Single-Use Intraocular Injection, Imprimis NJOF,
Recalled January 14, 2026 · FDA recall D-0250-2026 · Imprimis NJOF
Hazard
Presence of particulate matter - Glass like particles. · FDA Class II
Units
596 boxes of 11,920 pre-filled syringes
Sold at
U.S Nationwide
Description
Presence of particulate matter - Glass like particles.
Product
Dexamethasone Moxifloxacin Ketorolac, 1 mg/mL, 0.5 mg/mL, 0.4 mg/mL) Single-Use Intraocular Injection, Imprimis NJOF, LLC., 1705 Route 46 West, Unit 6B, Ledgewood, NJ 07852, NDC 71384-513-01.
Manufacturer(s)
Imprimis NJOF, LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →